One recent study reported a potential efficacy of epigenetic drug combination, inhibitors of histone deacetylases (HDAC) and lysine-specific demethylase 1 (LSD1), in Ewing sarcoma xenograft models (Garcia-Dominguez et al, 2018). The gene discussed is HDAC9; the disease is Ewing sarcoma.